Live Breaking News & Updates on Thorac Oncol

Stay updated with breaking news from Thorac oncol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South Korea , National Cancer Database , American College Of Chest Physicians , Cancer Statistics , Practice Guidelines , Natl Compr Canc Netw , American College , Chest Physicians , National Cancer , Thorac Surg , Englj Med , Thorac Oncol , Clin Oncol ,

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Sloan Kettering , Van Coevorden , J Thorac Cardiovasc , European Society For Radiotherapy , European Organisation For Research , Clin Oncol , Thorac Cardiovasc Surg , Natl Cancer Inst , European Society , European Organisation , Cancer Res , Thorac Oncol , Sloan Kettering Integrated Mutation Profiling , Actionable Cancer Targets , Mol Diagn ,